DK538485D0 - Rekombinante dna-molekyler - Google Patents

Rekombinante dna-molekyler

Info

Publication number
DK538485D0
DK538485D0 DK538485A DK538485A DK538485D0 DK 538485 D0 DK538485 D0 DK 538485D0 DK 538485 A DK538485 A DK 538485A DK 538485 A DK538485 A DK 538485A DK 538485 D0 DK538485 D0 DK 538485D0
Authority
DK
Denmark
Prior art keywords
recombinant dna
dna molecules
molecules
recombinant
dna
Prior art date
Application number
DK538485A
Other languages
Danish (da)
English (en)
Other versions
DK538485A (da
Inventor
A R Dunn
N M Gough
D Metcalf
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3770545&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK538485(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Research Corp filed Critical Research Corp
Publication of DK538485A publication Critical patent/DK538485A/da
Publication of DK538485D0 publication Critical patent/DK538485D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK538485A 1984-03-21 1985-11-21 Rekombinante dna-molekyler DK538485D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPG417384 1984-03-21
PCT/US1985/000465 WO1985004188A1 (fr) 1984-03-21 1985-03-19 Molecules d'adn recombinant

Publications (2)

Publication Number Publication Date
DK538485A DK538485A (da) 1985-11-21
DK538485D0 true DK538485D0 (da) 1985-11-21

Family

ID=3770545

Family Applications (1)

Application Number Title Priority Date Filing Date
DK538485A DK538485D0 (da) 1984-03-21 1985-11-21 Rekombinante dna-molekyler

Country Status (8)

Country Link
US (1) US5602007A (fr)
EP (2) EP0574029A1 (fr)
JP (3) JPS61501490A (fr)
AU (2) AU594014B2 (fr)
DE (1) DE3587864T2 (fr)
DK (1) DK538485D0 (fr)
NL (1) NL940022I1 (fr)
WO (1) WO1985004188A1 (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR860001471B1 (ko) 1980-04-03 1986-09-26 비오겐 엔. 브이 인체의 섬유아세포 인터페론(IFN-β)폴리펩티드의 제조방법
EP0188479B1 (fr) * 1984-07-06 1991-09-11 Sandoz Ag Production et purification de lymphokine
JPS61227526A (ja) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
UA29377C2 (uk) * 1984-09-19 2000-11-15 Новартіс Аг Спосіб отримання білка з активністю колонієстимулювального фактора гранулоцитів та макрофагів(gm-csf) приматів
AU608741B2 (en) * 1984-11-20 1991-04-18 Schering Biotech Corporation cDNA clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophil cellular growth factor activity
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
DE3681551D1 (de) * 1985-09-30 1991-10-24 Chugai Pharmaceutical Co Ltd Menschlicher granulozyten-colony stimulierender faktor.
JPH0618778B2 (ja) * 1985-10-04 1994-03-16 中外製薬株式会社 白血球減少症治療剤
DE3545568A1 (de) * 1985-12-21 1987-07-16 Hoechst Ag Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung
US5298603A (en) * 1985-12-21 1994-03-29 Hoechst Aktiengesellschaft GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use
EP0232707A1 (fr) * 1986-01-09 1987-08-19 Ajinomoto Co., Inc. Facteur humain d'augmentation de la croissance de cellules hématopoiétiques
US5106733A (en) * 1987-06-25 1992-04-21 Immunex Corporation Bovine granulocyte-macrophage colony stimulating factor
EP0413721A4 (en) * 1988-04-21 1991-11-13 Medvet Science Pty. Ltd. Human gm-csf variants
SG59954A1 (en) * 1989-08-11 1999-02-22 Amrad Corp Ltd Improvements in granulocyte-macrophage colony- stimulating factor receptor and derivatives thereof
EP0711829A3 (fr) 1993-09-15 1997-07-09 Viagene Inc Vecteurs composés d'alphavirus recombinants
EP0791061A4 (fr) * 1994-03-04 1998-07-15 Ludwig Inst Cancer Res Animaux a rupture genique ciblee
EP1997900A3 (fr) 1996-04-05 2010-10-06 Novartis Vaccines and Diagnostics, Inc. Vecteurs à base d'alpha virus recombinants avec inhibition réduite de synthèse macromoléculaire cellulaire
WO1998012332A1 (fr) 1996-09-17 1998-03-26 Chiron Corporation Compositions et procedes de traitement de maladies intracellulaires
US6753165B1 (en) * 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
AU751898B2 (en) * 1997-07-14 2002-08-29 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
EP1019082B2 (fr) 1997-10-02 2008-06-04 Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E.V. Utiliastion d'un facteur des colonies (csf) pour augmenter la croissance collaterale des arteres collaterales et/ou d'autres arteres a partir de connexions arteriolaires preexistantes
US7935805B1 (en) 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
EP1980617A1 (fr) 1998-12-31 2008-10-15 Novartis Vaccines and Diagnostics, Inc. Expression améliorée de polypeptides HIV et production de particules de type virus
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
ATE446767T1 (de) * 1999-02-12 2009-11-15 Univ Washington Gm-csf zur behandlung von morbus crohn
US6911204B2 (en) * 2000-08-11 2005-06-28 Favrille, Inc. Method and composition for altering a B cell mediated pathology
US20030012782A1 (en) * 2000-08-11 2003-01-16 Gold Daniel P. Method and composition for altering a T cell mediated pathology
CA2452119C (fr) 2001-07-05 2013-10-15 Chiron Corporation Polynucleotides codant pour des polypeptides antigeniques du vih de sous-type b et/ou de sous-type c, polypeptides et leurs utilisations
CA2634992C (fr) 2001-07-05 2012-10-16 Novartis Vaccines And Diagnostics, Inc. Polynucleotides codant des polypeptides de type c du vih antigeniques, polypeptides et leurs utilisations
US7714113B2 (en) 2002-02-13 2010-05-11 Ludwig Institute For Cancer Research Fusion proteins of humanized g250 specific antibodies and uses thereof
ES2627445T3 (es) 2002-05-01 2017-07-28 Miltenyi Biotec Technology, Inc. Partículas de vector de lentivirus resistentes a la inactivación por el complemento
GB0210741D0 (en) * 2002-05-10 2002-06-19 Medical Res Council Methods of therapy
GB0224415D0 (en) * 2002-10-21 2002-11-27 Medical Res Council Compositions
AU2004269320B2 (en) 2003-06-20 2009-12-24 Protein Sciences Corporation Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
WO2006050394A2 (fr) 2004-11-01 2006-05-11 Novartis Vaccines And Diagnostics Inc. Approches combinatoires destinees a produire des reponses immunitaires
GB0524103D0 (en) * 2005-11-26 2006-01-04 Medical Res Council Healing
CA2641169C (fr) 2006-02-08 2017-05-02 Morphotek, Inc. Peptides antigeniques du facteur de stimulation de colonie de granulocytes (gm-csf) et anticorps au gm-csf
WO2007137300A2 (fr) 2006-05-23 2007-11-29 Bellicum Pharmaceuticals, Inc. Cellules dendritiques modifiées à survie et immunogénicité améliorées et compositions et procédés connexes
EP2498795B1 (fr) 2009-10-12 2016-12-07 The United States Of America, As Represented By The Secretary, Department of Health and Human Services Granulysine dans l'immunothérapie
WO2012093258A2 (fr) 2011-01-05 2012-07-12 Imperial Innovations Limited Traitement et criblage
EP2870238A4 (fr) 2012-07-05 2016-03-09 Ohio State Innovation Foundation Compositions et procédés associés à des vaccins viraux
EP3344290A4 (fr) 2015-08-31 2019-02-27 Technovax, Inc. Vaccin à base de pseudoparticules virales (vlp) contre le virus syncytial respiratoire humain (hrsv)
EP3805376A1 (fr) 2016-01-08 2021-04-14 Replimune Limited Virus modifié
US10538786B2 (en) 2016-04-13 2020-01-21 Janssen Pharmaceuticals, Inc. Recombinant arterivirus replicon systems and uses thereof
AU2017347725B2 (en) 2016-10-17 2024-01-04 Janssen Pharmaceuticals, Inc. Recombinant virus replicon systems and uses thereof
MX2019006467A (es) 2016-12-05 2019-12-09 Janssen Pharmaceuticals Inc Star Composiciones y métodos para mejorar la expresión génica.
GB201700350D0 (en) 2017-01-09 2017-02-22 Replimune Ltd Altered virus
EA202091516A1 (ru) 2017-12-19 2020-11-03 Янссен Сайенсиз Айрлэнд Анлимитед Компани Способы и композиции для индукции иммунного ответа против вируса гепатита b (hbv)
US11389531B2 (en) 2017-12-19 2022-07-19 Janssen Sciences Ireland Unlimited Company Methods and apparatus for the delivery of hepatitis B virus (HBV) vaccines
US11021692B2 (en) 2017-12-19 2021-06-01 Janssen Sciences Ireland Unlimited Company Hepatitis B virus (HBV) vaccines and uses thereof
KR20200111729A (ko) 2018-01-19 2020-09-29 얀센 파마슈티칼즈, 인코포레이티드 재조합 레플리콘 시스템을 이용한 면역 반응 유도 및 증진

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN150740B (fr) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
US4658018A (en) * 1984-03-13 1987-04-14 Immunex Corporation Process for producing homogeneous colony stimulating factor
EP0188479B1 (fr) * 1984-07-06 1991-09-11 Sandoz Ag Production et purification de lymphokine
AU608741B2 (en) * 1984-11-20 1991-04-18 Schering Biotech Corporation cDNA clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophil cellular growth factor activity
US4810643A (en) * 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
US5298603A (en) * 1985-12-21 1994-03-29 Hoechst Aktiengesellschaft GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use

Also Published As

Publication number Publication date
DE3587864T2 (de) 1994-09-29
DE3587864D1 (de) 1994-07-28
JPS61501490A (ja) 1986-07-24
DK538485A (da) 1985-11-21
AU629938B2 (en) 1992-10-15
AU5589390A (en) 1990-09-13
US5602007A (en) 1997-02-11
AU4008485A (en) 1985-09-26
EP0177568B1 (fr) 1994-06-22
NL940022I1 (nl) 1995-01-02
AU594014B2 (en) 1990-03-01
JPH09271A (ja) 1997-01-07
EP0177568A1 (fr) 1986-04-16
EP0177568A4 (fr) 1987-10-08
WO1985004188A1 (fr) 1985-09-26
JPH10165190A (ja) 1998-06-23
EP0574029A1 (fr) 1993-12-15

Similar Documents

Publication Publication Date Title
DK538485A (da) Rekombinante dna-molekyler
DK467385D0 (da) Dna-fragmenter
DK552285A (da) Proteinkonjugat
DK112586D0 (da) Virus-dna
DK180486D0 (da) Varmeapparat
DK224886A (da) Proteinbestemmelse
DE3683186D1 (de) Rekombinantes humaninterleukin-1.
GB8404378D0 (en) Dna sequence recombinant dna molecules
BR8600164A (pt) Coluna de fracionamento
DK600586A (da) Protein
NO170503C (no) Broennhull-proevetaker
DK395385A (da) Varmeapparat
FI852866L (fi) Rekombinantfaktor viii-r.
DE3582362D1 (de) Elektrophoretisches element.
DK319888D0 (da) Dna-fragmenter
GB8406569D0 (en) Recombinant dna molecules
GB8319265D0 (en) Recombinant dna molecules
NO850732L (no) Rekombinante dna-molekyler
DK51585A (da) Proteinkoncentrater
DK161609C (da) Elektroforeseanordning
GB8619300D0 (en) Recombinant dna molecules
ES278395Y (es) Pipeta mejorada
DK286D0 (da) Elektroforeseapparat
GB8405655D0 (en) Molecules by electrophoresis
SE8505275D0 (sv) Armering

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment